What is ketorolac used for?

Indications and Usage, quoted from the label by Civica, Inc. (ANDA209900). Cross-references to other label sections are left out.

Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ).

Acute Pain in Adult Patients

Ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary.

The total combined duration of use of ketorolac tromethamine injection and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see WARNINGS, PRECAUTIONS, DOSAGE AND ADMINISTRATION, and ADVERSE REACTIONS ). Patients should be switched to alternative analgesics as soon as possible, but ketorolac tromethamine therapy is not to exceed 5 days.

Source: DailyMed label, set id 1e8ddf13-c513-4e16-a91a-9d55726d9071, version 3, effective November 4, 2024. NDC 72572-354, one of 73 listings for this product.

Indications and Usage, quoted from the label by Injecta Medcial LLC (ANDA216651). Cross-references to other label sections are left out.

Carefully consider the potential benefits and risks of ketorolac tromethamine tablets USP and other treatment options before deciding to use ketorolac tromethamine tablets USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

Acute Pain in Adult Patients

Ketorolac tromethamine tablets USP are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with IV or IM dosing of ketorolac tromethamine and ketorolac tromethamine tablets USP are to be used only as continuation treatment, if necessary.

The total combined duration of use of ketorolac tromethamine tablets USP and ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see WARNINGS, PRECAUTIONS, DOSAGE AND ADMINISTRATION, and ADVERSE REACTIONS). Patients should be switched to alternative analgesics as soon as possible, but Ketorolac Tromethamine Tablet USP therapy is not to exceed 5 days.

Source: DailyMed label, set id 515464a7-16c5-2811-e063-6294a90aa451, version 4, effective June 18, 2026. NDC 87234-7695, one of 53 listings for this product.